DEF 14A: NorthView Acquisition Corp. Seeks Extension to Complete Business Combination with Profusa

NorthView Acquisition Corp. is seeking stockholder approval to extend the deadline for completing a business combination from March 22, 2025, to as late as June 22, 2025, to allow more time to finalize its merger with Profusa, Inc.

Summary

• NorthView Acquisition Corp. is holding a special meeting of stockholders on March 18, 2025, to vote on proposals to extend the deadline for completing a business combination.
• The primary proposal is to amend the company's charter to extend the deadline from March 22, 2025, monthly for up to three additional months, ultimately until as late as June 22, 2025.
• The extension requires monthly contributions of the lesser of $10,000 or $0.04 per outstanding public share.
• Stockholders also will vote on amendments to the Trust Agreement and the company's charter related to net tangible assets.
• The company is pursuing a business combination with Profusa, Inc., but believes it needs more time to complete the transaction.
• If the extension is not approved, the company will liquidate and redeem public shares at an estimated price of $12.19 per share.
• If the extension is approved, stockholders can redeem their shares for cash.
• The company's board recommends voting in favor of the extension.
• The company's securities were suspended from trading and delisted from Nasdaq on December 27, 2024, and are currently traded on OTC Pink Markets.

Sentiment

Score: 5

Explanation: The document is neutral in tone, presenting the facts and proposals related to the extension. The delisting from Nasdaq is a negative factor, but the board is recommending the extension, suggesting they believe it is the best course of action.

Positives

• The extension provides stockholders with the opportunity to consider a business combination with Profusa.
• Stockholders retain the right to redeem their shares if the extension is approved and they do not wish to participate in the business combination.
• The board believes the extension is in the best interests of stockholders.

Negatives

• If the extension is approved, the amount remaining in the trust account may be only a small fraction of the approximately $8.3 million that was in or owed to the Trust Account as of February 21, 2025.
• The company's securities were suspended from trading and delisted from Nasdaq on December 27, 2024, and are currently traded on OTC Pink Markets.
• There is no guarantee that the business combination will be completed even if the extension is approved.

Risks

• If the extension is not approved, the company will liquidate, and stockholders may receive less than the initial IPO price per share.
• The company may need to obtain additional funds to complete the business combination, and there is no assurance that such funds will be available.
• The company's securities were suspended from trading and delisted from Nasdaq on December 27, 2024, and are currently traded on OTC Pink Markets.
• Delays in causing extension payments to be funded to the Trust Account may contradict our governing documents.
• A 1% U.S. federal excise tax could be imposed on the Company in connection with redemptions by Company of its shares in connection with a business combination or other stockholder vote.

Future Outlook

The company intends to hold another stockholder meeting prior to the Extended Date in order to seek stockholder approval of the business combination with Profusa. If the Extension Proposal is not approved, or if it is approved but the company does not consummate a business combination before the Extended Date, the Company will dissolve and liquidate.

Management Comments

• Our Board currently believes that there will not be sufficient time before March 22, 2025, to complete the Business Combination with Profusa.
• Accordingly, the Board believes that in order to be able to consummate a business combination, we will need to obtain the Extension and that, without the Extension, we would be precluded from completing a business combination and would be forced to liquidate even if our stockholders are otherwise in favor of consummating a business combination.

Industry Context

This announcement is typical for SPACs approaching their deadline to complete a business combination. Many SPACs seek extensions to provide more time to find and close a deal, often requiring additional capital contributions from sponsors.

Comparison to Industry Standards

• The estimated redemption price of $12.19 per share is above the typical $10.00 NAV for SPACs, indicating potential interest income earned in the trust account.
• The monthly extension contribution of the lesser of $10,000 or $0.04 per share is a common mechanism used by SPACs to incentivize stockholders to forgo redemption and allow the company to continue its search for a target.
• The delisting from Nasdaq is a significant setback, as it makes it more difficult to complete a business combination and maintain investor confidence. Comparible companies such as Digital World Acquisition Corp. (DWAC) have faced similar challenges with listing requirements and regulatory hurdles.

Stakeholder Impact

• Stockholders will have the opportunity to vote on the extension and redeem their shares.
• If the extension is not approved, stockholders will receive a pro rata share of the trust account upon liquidation.
• The company's sponsor, directors, and officers have a financial interest in the extension being approved, as their founder shares and warrants would expire worthless if the company liquidates.

Next Steps

• Stockholders will vote on the proposals at the Special Meeting on March 18, 2025.
• If the extension is approved, the company will file an amendment to the charter with the Secretary of State of the State of Delaware.
• The company will continue to work to consummate the business combination with Profusa by the Extended Date.
• If the business combination is completed, the company expects to relist on The Nasdaq Stock Market.

Key Dates

Keywords

business combination, extension, redemption, Profusa, NorthView Acquisition Corp., SPAC, trust account, liquidation